-DOCSTART- -X- O
Acute -X- _ B-Patient
lung -X- _ I-Patient
injury -X- _ I-Patient
is -X- _ O
characterized -X- _ O
by -X- _ O
intense -X- _ O
neutrophilic -X- _ O
lung -X- _ O
inflammation -X- _ O
and -X- _ O
increased -X- _ O
alveolar-capillary -X- _ O
barrier -X- _ O
permeability -X- _ O
leading -X- _ O
to -X- _ O
severe -X- _ O
hypoxemia -X- _ O
, -X- _ O
and -X- _ O
is -X- _ O
associated -X- _ O
with -X- _ O
high -X- _ O
mortality -X- _ O
despite -X- _ O
improvements -X- _ O
in -X- _ O
supportive -X- _ O
care. -X- _ O
There -X- _ O
is -X- _ O
an -X- _ O
urgent -X- _ O
need -X- _ O
for -X- _ O
effective -X- _ O
therapies -X- _ O
for -X- _ O
acute -X- _ B-Patient
lung -X- _ I-Patient
injury. -X- _ I-Patient
Zhang -X- _ O
and -X- _ O
colleagues -X- _ O
tested -X- _ O
the -X- _ O
efficacy -X- _ O
of -X- _ O
adipose-derived -X- _ B-Intervention
stem -X- _ I-Intervention
cells -X- _ I-Intervention
in -X- _ O
acute -X- _ B-Patient
lung -X- _ I-Patient
injury -X- _ I-Patient
in -X- _ I-Patient
mice. -X- _ I-Patient
When -X- _ B-Outcome
adipose-derived -X- _ I-Outcome
stem -X- _ I-Outcome
cells -X- _ I-Outcome
were -X- _ I-Outcome
delivered -X- _ I-Outcome
to -X- _ I-Outcome
mice -X- _ I-Outcome
that -X- _ I-Outcome
had -X- _ I-Outcome
been -X- _ I-Outcome
challenged -X- _ I-Outcome
with -X- _ I-Outcome
lipopolysaccharide -X- _ I-Outcome
, -X- _ I-Outcome
they -X- _ I-Outcome
potently -X- _ I-Outcome
limited -X- _ I-Outcome
acute -X- _ I-Outcome
lung -X- _ I-Outcome
inflammation -X- _ I-Outcome
and -X- _ I-Outcome
injury -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
mice -X- _ I-Outcome
, -X- _ I-Outcome
indicating -X- _ I-Outcome
that -X- _ I-Outcome
adipose-derived -X- _ I-Outcome
stem -X- _ I-Outcome
cells -X- _ I-Outcome
have -X- _ I-Outcome
therapeutic -X- _ I-Outcome
potential -X- _ I-Outcome
in -X- _ I-Outcome
acute -X- _ I-Outcome
lung -X- _ I-Outcome
injury -X- _ I-Outcome
in -X- _ I-Outcome
humans. -X- _ I-Outcome
Herein -X- _ O
, -X- _ O
we -X- _ O
discuss -X- _ O
the -X- _ O
advantages -X- _ O
and -X- _ O
potential -X- _ O
limitations -X- _ O
of -X- _ O
using -X- _ O
adipose-derived -X- _ B-Intervention
stem -X- _ I-Intervention
cells -X- _ I-Intervention
as -X- _ O
therapeutics -X- _ O
for -X- _ O
human -X- _ B-Patient
acute -X- _ I-Patient
lung -X- _ I-Patient
injury -X- _ I-Patient
. -X- _ O

